What?
The National Health Service (NHS) has announced a significant expansion of the eligibility criteria for shingles vaccination starting this September. This extension will make nearly one million more people (900,000) qualified for the Shingrix vaccine, known for its effectiveness in preventing shingles – a painful rash caused by reactivation of the chickenpox virus.
At present, the vaccine is only available to individuals over 70. However, the new initiative will extend the eligibility to those severely immunosuppressed and over 50, and people turning 65 and 70. NHS expects to broaden the eligible age group to 60 and up by September 2033. Patients will be informed by their GP practice when they become eligible for the vaccination.
Shingles, a condition that cannot achieve herd immunity, can develop at any age but the risk and severity increase with age and in individuals with a weakened immune system. About nine in 10 adults are infected with the virus that causes shingles, and approximately one in four people will develop shingles in their lifetime. Serious cases can result in complications such as blindness, nerve pain, hearing loss, and in some cases, death.
Why?
This landmark decision comes in response to the recommendations of the Joint Committee of Vaccination and Immunisation (JCVI), following trials that showed the Shingrix vaccine’s high effectiveness and safety in a broader cohort of people. It is aimed at mitigating the risks posed by shingles, especially for older adults and immunocompromised individuals, who are particularly vulnerable to severe complications.
Shingles cannot be caught from others; instead, it arises in those previously infected with chickenpox, which can manifest mildly, making some people unaware of past infection. However, studies show nearly every adult has had the virus, and with age, the risk of developing shingles increases.
While the world has been primarily focused on the Covid and flu vaccines, it is important to remember that there are other preventable illnesses like shingles, which can have devastating effects on those most at risk.
How (does it affect you)?
This expansion of the vaccination programme means that a larger group of healthcare consumers and patients in the NHS will have access to the preventive care needed to guard against shingles. This initiative is vital as it significantly reduces the risk of developing shingles and experiencing severe symptoms.
For patients wondering how to avail of this service, it’s straightforward. Upon becoming eligible, your GP practice will reach out to you. You might also be offered the vaccine during routine visits or check-ups. This move ensures getting the jab is as convenient as possible.
If you fall into the category of those severely immunosuppressed and over 50 or are turning 65 and 70 after 1st September 2023, you will be eligible for the vaccine. If you are currently aged 70-80, you are already eligible. Remember, even if you think you may not be at risk or have never had chickenpox, it’s crucial to get the vaccine if eligible.
It’s also noteworthy that anyone already vaccinated against shingles, specifically with the Zostavax vaccine, or immunocompromised individuals who have received two doses of Shingrix, do not need re-vaccination.
With this move, the NHS is sending a strong message: Preventive healthcare is a top priority, and it’s essential that patients take up these services to ensure their overall well-being. So, don’t delay your vaccination. Speak to your GP or practice nurse to learn more and to arrange for your shingles vaccine when you become eligible. In doing so, you are taking an active step in managing your health, preventing serious illness, and potentially saving lives.
